JOURNEY MEDICAL CORPORATION - COMMON STOCK

Journey Medical Corporation Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights

12 نوفمبر 2024 16:01:12 بحسب Nasdaq GlobeNewswire

Journey Medical Corporation Announces U.S. FDA Approval of Emrosi™ (Minocycline Hydrochloride Extended Release Capsules, 40 mg) for the Treatment of Rosacea

04 نوفمبر 2024 07:00:53 بحسب Nasdaq GlobeNewswire

Journey Medical Corporation Announces DFD-29 Data Presented at 44th Fall Clinical Dermatology Conference

25 أكتوبر 2024 08:30:35 بحسب Nasdaq GlobeNewswire

Journey Medical Corporation to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference

03 أكتوبر 2024 08:30:23 بحسب Nasdaq GlobeNewswire

Journey Medical Corporation to Participate in the Lake Street Capital Markets 8th Annual Best Ideas Growth (BIG) Conference

09 سبتمبر 2024 08:30:35 بحسب Nasdaq GlobeNewswire

Journey Medical Corporation to Present at the H.C. Wainwright 26th Annual Global Investment Conference

04 سبتمبر 2024 08:15:03 بحسب Nasdaq GlobeNewswire

Journey Medical Corporation Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights

12 أغسطس 2024 16:01:35 بحسب Nasdaq GlobeNewswire

Journey Medical Corporation to Announce Second Quarter 2024 Financial Results on August 12, 2024

06 أغسطس 2024 16:01:38 بحسب Nasdaq GlobeNewswire

Journey Medical Corporation Appoints Michael C. Pearce to Board of Directors

11 يوليو 2024 16:05:39 بحسب Nasdaq GlobeNewswire

Journey Medical Corporation to Participate in the Alliance Global Partners’ (A.G.P.) Virtual Healthcare Company Showcase

15 مايو 2024 16:01:52 بحسب Nasdaq GlobeNewswire

Journey Medical Corporation Reports First Quarter 2024 Financial Results and Recent Corporate Highlights

13 مايو 2024 16:01:47 بحسب Nasdaq GlobeNewswire

Journey Medical Corporation to Announce First Quarter 2024 Financial Results on May 13, 2024

07 مايو 2024 08:30:10 بحسب Nasdaq GlobeNewswire

Journey Medical Corporation Appoints Joseph Benesch as Chief Financial Officer

01 مايو 2024 16:01:30 بحسب Nasdaq GlobeNewswire

Journey Medical Corporation to Present at the Planet MicroCap Showcase: Vegas 2024

25 أبريل 2024 08:30:48 بحسب Nasdaq GlobeNewswire

Journey Medical Corporation Reports Full-Year 2023 Financial Results and Recent Corporate Highlights

21 مارس 2024 16:01:27 بحسب Nasdaq GlobeNewswire

Journey Medical Corporation Announces U.S. FDA Acceptance of New Drug Application for DFD-29 for the Treatment of Rosacea

18 مارس 2024 08:30:30 بحسب Nasdaq GlobeNewswire

Journey Medical Corporation to Announce Year End 2023 Financial Results on March 21, 2024

15 مارس 2024 08:30:01 بحسب Nasdaq GlobeNewswire

Journey Medical Corporation to Participate in the 36th Annual ROTH Conference

13 مارس 2024 08:30:14 بحسب Nasdaq GlobeNewswire

Journey Medical Corporation Submits New Drug Application to FDA for DFD-29 to Treat Rosacea

05 يناير 2024 08:30:12 بحسب Nasdaq GlobeNewswire

Journey Medical Corporation Secures Credit Facility with SWK Holdings for up to $20 Million

02 يناير 2024 16:05:30 بحسب Nasdaq GlobeNewswire